Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter By: MarketWatch February 02, 2023 at 13:49 PM EST The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations. Read More >> Related Stocks: Eli Lilly Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter By: MarketWatch February 02, 2023 at 13:49 PM EST The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations. Read More >> Related Stocks: Eli Lilly